MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1200/po.24.00206

Медицинская библиотека · JCO precision oncology · 2024

Extrahepatic Cholangiocarcinoma: Genomic Variables Associated With Anatomic Location and Outcome.

Preston William A, Drill Esther, Boerner Thomas, Gelfer Rebecca, Harding James J, O'Reilly Eileen M, Cercek Andrea, Abou-Alfa Ghassan, Park Wungki, Balachandran Vinod P, Drebin Jeffrey, Soares Kevin C, Wei Alice, Kingham T Peter, D'Angelica Michael I, Jarnagin William R

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

PURPOSE: This study aimed to define genomic differences between perihilar cholangiocarcinoma (PCA) and distal cholangiocarcinoma (DCA) and identify genomic determinants of survival.

MATERIALS AND

METHODS

Consecutive patients with ECA with tissue for targeted next-generation sequencing were analyzed, stratified by anatomic site (PCA/DCA), disease extent, and treatment. Associations between genomic alterations, clinicopathologic features, and outcomes were analyzed using Cox proportional hazards regression to compare survival.

RESULTS

In total, 224 patients diagnosed between 2004 and 2022 (n = 127 PCA; n = 97 DCA) met inclusion criteria. The median survival was 29 months (43 after resection and 17 from diagnosis for unresectable disease). Compared with PCA, DCA was enriched in TP53alt (alterations; 69% v 33%; Q < 0.01), epigenetic pathway alterations (45% v 29%; Q = 0.041), and had more total altered pathways (median 3 v 2; Q < 0.01). KRASalt frequency was similar between PCA (36%) and DCA (37%); however, DCA was enriched in KRAS G12D (19% v 9%; P = .002). No other clinicopathologic or genomic variables distinguished subtypes. In resected patients, no genomic alterations were associated with outcome. However, in unresectable patients, CDKN2Aalt (hazard ratio [HR], 2.59 [1.48 to 4.52]) and APCalt (HR, 5.11 [1.96 to 13.3]) were associated with reduced survival. For the entire cohort, irresectability (HR, 3.13 [2.25 to 4.36]), CDKN2Aalt (HR, 1.80 [1.80 to 2.68]), and APCalt (HR, 2.00 [1.04 to 3.87]) were associated with poor survival.

CONCLUSION

CDKN2Aalt and APCalt were associated with poor survival in ECA, primarily in advanced disease. As PCA and DCA were genetically similar, coanalysis of PCA and DCA in future genomic studies is reasonable.

Для цитирования: Preston William A, Drill Esther, Boerner Thomas, Gelfer Rebecca, Harding James J, O'Reilly Eileen M, Cercek Andrea, Abou-Alfa Ghassan, Park Wungki, Balachandran Vinod P, Drebin Jeffrey, Soares Kevin C, Wei Alice, Kingham T Peter, D'Angelica Michael I, Jarnagin William R. Extrahepatic Cholangiocarcinoma: Genomic Variables Associated With Anatomic Location and Outcome.. JCO precision oncology. 2024. DOI: 10.1200/po.24.00206.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.